Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 213.00K | 52.00K | 232.00K | 104.00K | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 213.00K | 52.00K | 232.00K | 104.00K | 0.00 |
| Cost of Revenue | 12.55M | -- | 3.86M | 3.38M | 16.57M |
| Gross Profit | -12.33M | 52.00K | -3.63M | -3.28M | -16.57M |
| SG&A Expenses | 1.47M | 1.44M | 2.09M | 1.80M | 1.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.60M | 4.60M | 5.95M | 5.18M | 4.99M |
| Operating Income | -3.39M | -4.55M | -5.72M | -5.07M | -4.99M |
| Income Before Tax | -3.37M | -5.73M | -5.63M | -3.90M | -3.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.37M | -5.73M | -5.63M | -3.90M | -3.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.37M | -5.73M | -5.63M | -3.90M | -3.32M |
| EBIT | -3.39M | -4.55M | -5.72M | -5.07M | -4.99M |
| EBITDA | -3.37M | -4.53M | -5.70M | -5.05M | -4.96M |
| EPS Basic | -1.05 | -2.83 | -3.10 | -2.94 | -3.29 |
| Normalized Basic EPS | -0.65 | -1.77 | -1.94 | -1.84 | -2.06 |
| EPS Diluted | -1.05 | -2.83 | -3.10 | -2.94 | -3.29 |
| Normalized Diluted EPS | -0.65 | -1.77 | -1.94 | -1.84 | -2.06 |
| Average Basic Shares Outstanding | 3.22M | 2.03M | 1.82M | 1.33M | 1.01M |
| Average Diluted Shares Outstanding | 3.22M | 2.03M | 1.82M | 1.33M | 1.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |